IRC
CNMD icon

Investors Research Corp’s CONMED CNMD Stock Holding History

Investors Research Corp’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$19.2K Hold
415
– – ﹤0.01% 478
2026
Q2 		$13.6K Hold
415
– – ﹤0.01% 506
2026
Q1 		$14.7K Buy
415
+15
+4% +$610 ﹤0.01% 511
2025
Q4 		$16.2K Buy
+400
New +$17.4K ﹤0.01% 570

Other funds holding CNMD

CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
EP
EPIQ Partners Minneapolis, Minnesota $232M AUM 9.01% 1-Year Est. Return
FAM
Fenimore Asset Management Cobleskill, New York $4.55B AUM 5.53% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

Investors Research Corp's CNMD Position: Q3 2026 in Review

Investors Research Corp held its CONMED (CNMD) position steady in Q3 2026 at 415 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #478.

Investors Research Corp first reported a position in CNMD in Q4 2025 and has held it in 4 quarters since. 11 funds tracked by Wall St. Rank hold CNMD as of Q3 2026.

  • Investors Research Corp held 415 shares of CONMED worth $19.2K as of Q3 2026.
  • Investors Research Corp left its CONMED share count unchanged in Q3 2026.
  • CONMED made up ﹤0.01% of Investors Research Corp's portfolio in Q3 2026, its #478 holding.
  • Investors Research Corp first reported a position in CONMED in Q4 2025 and has held it in 4 quarters since.
  • 11 funds tracked by Wall St. Rank held CONMED as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.